EurekAlert! News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 29-Jun-2026 03:15 ET (29-Jun-2026 07:15 GMT/UTC)

31-Mar-2026

Dartmouth Cancer Center names internationally renowned cancer research pioneer Roy Herbst, MD, Ph.D., as its next leader

Dartmouth Cancer Center (DCC) has appointed Roy S. Herbst, MD, PhD, as the center’s sixth director. Herbst will lead integrated efforts to help strengthen cancer research, education, and collaboration across Dartmouth and Dartmouth Health, expand access to advanced treatments and clinical trials, and continue to elevate cancer care in southern New Hampshire, throughout New England, and beyond.

31-Mar-2026

Researchers identify the keys to preventing hospitalizations during nursing home flu outbreaks

Brown University
Peer-Reviewed Publication

A new study led by researchers from Brown’s School of Public Health could inform real-world outbreak management and clarify key guidelines for nursing home staff and clinicians.

Journal: JAMA Internal Medicine

31-Mar-2026

Plastic additives tied to millions of preterm births worldwide

NYU Langone Health / NYU Grossman School of Medicine
Peer-Reviewed Publication

Exposure to a chemical commonly used to make plastic more flexible may have contributed to about 1.97 million preterm births in 2018 alone, or more than 8 percent of the world’s total, a new analysis of population surveys shows. The chemical was also linked to the deaths of 74,000 newborns, the researchers further estimate.

Journal: EBioMedicine
Funder: Beyond Petrochemicals

31-Mar-2026

Single nutrient fuels cancer-fighting power of T cells

Johns Hopkins Medicine
Peer-Reviewed Publication

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Bloomberg School of Public Health have discovered how the immune system’s CD8+ T cells use the nutrient cysteine to control two essential functions that compete for this resource — the immune cell’s ability to multiply and its ability to kill cancer cells.

Journal: Cell
Funder: Van Andel Institute Metabolism & Nutrition, Pathway-to-Independence Award, Canadian Institutes of Health Research, Paul G. Allen Frontiers Group Distinguished Investigator Program, Chan Zuckerberg Initiative, Bloomberg Distinguished Professorship

31-Mar-2026

Is longevity science stuck? Researchers call for a strategic reset

Mitochondria-Microbiota Task Force
Meeting Announcement

After decades of progress, longevity science may be facing a paradox: more knowledge, but limited impact. Some researchers now suggest the field may have failed not because of insufficient data, but because of flawed strategy.

31-Mar-2026

Markers of lymphoma cancer relapse identified

University of Missouri-Columbia
Peer-Reviewed Publication

Researchers from the University of Missouri School of Medicine may have found a way to identify the patients at risk of recurrence for follicular lymphoma cancer without the need for imaging and surveillance testing by screening patients for several diffferent biomarkers.

Journal: American Journal of Clinical Oncology

31-Mar-2026

HonorHealth Research Institute patient receives new type of lumbar spine disc repair, alleviating pain and restoring range of motion

HonorHealth Research Institute
Reports and Proceedings

For the first time in Arizona, and only the second time in the U.S., HonorHealth Research Institute treated a patient with a new type of lumbar spine disc repair that provides immediate relief of pain and maintains the patient’s full range of motion.

31-Mar-2026

Dr. Cameron J. Gettel to be honored at #AGS26 for cross-cutting work at the intersection of geriatrics, emergency care, and care transitions

American Geriatrics Society
Grant and Award Announcement

Today, @AmerGeriatrics @HealthinAging announces Dr. Cameron J. Gettel (@CameronGettel) as the 2026 recipient of the Jeffrey H. Silverstein Memorial Award for Emerging Investigators in the Surgical and Related Medical Specialties. https://bit.ly/4lYAauK

31-Mar-2026

New genetic ‘roadmap’ advances precision therapy for intrahepatic cholangiocarcinoma

BGI Genomics
Peer-Reviewed Publication

Intrahepatic cholangiocarcinoma (iCCA), the second most common primary liver cancer after hepatocellular carcinoma, remains one of the most challenging malignancies to treat due to its highly concealed and heterogeneous nature. A collaborative team from BGI Genomics and Zhongshan Hospital of Fudan University has now charted the molecular “chaos” of iCCA, providing a navigational framework for more precise diagnosis and treatment.. The research is published in Cell Reports Medicine.

Journal: Cell Reports Medicine